Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL144757 | 0.90 | FFAR3 (0.53) | FFAR3POLBALDH1A1HSD17B10HDAC3 | |
| Propionic Acid SCHEMBL146196 | 0.88 | FFAR3 (0.46) | FFAR3POLBALDH1A1HSD17B10 | |
| Propionic Acid SCHEMBL146710 | 0.86 | FFAR3 (0.48) | FFAR3POLBALDH1A1HSD17B10HDAC3 | |
| Butyric Acid SCHEMBL141716 | 0.85 | FFAR3 (0.54) | FFAR3ALDH1A1HSD17B10HDAC3HDAC1 | |
| Propionic Acid SCHEMBL3410619 | 0.84 | FFAR3 (0.67) | FFAR3ALDH1A1HSD17B10HDAC3HDAC1 | |
| Valeric Acid SCHEMBL144234 | 0.81 | AKR1B1 (0.50) | POLBALDH1A1HSD17B10 | |
| Propionic Acid SCHEMBL3721083 | 0.80 | FFAR3 (0.53) | FFAR3ALDH1A1HSD17B10HDAC3HDAC1 | |
| Propionic Acid SCHEMBL28314256 | 0.79 | — | — | |
| Propionic Acid SCHEMBL28145772 | 0.77 | FFAR3 (0.56) | FFAR3ALDH1A1HSD17B10HDAC3HDAC1 | |
| Tetrahydrofuran SCHEMBL27415023 | 0.77 | FFAR3 (0.56) | FFAR3ALDH1A1HSD17B10HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058057-A1 | Anti-dandruff Agents | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | US | claimed |
| WO-2010136104-A2 | ANTI-DANDRUFF AGENTS | MERCK PATENT GMBH (DE) | 2010-12-02 | — | — | WO | claimed |
| US-20120058057-A1 | Anti-dandruff Agents | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058057-A1 | Anti-dandruff Agents | POLR1C, ETF1, PIK3C3 | FFAR3 1689/4885POLB 1116/4885ALDH1A1 272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.